January 7, 2022
Currax Pharmaceuticals Appoints Michael Kyle, M.D., as Senior Vice President, Chief Medical Officer
Read moreOctober 26, 2021
Currax Pharmaceuticals Announces the Appointment of Ed Cinca to Senior Vice President, Global Marketing and Strategic Alliance Management
Read moreOctober 21, 2021
Currax Pharmaceuticals Granted Type C Meeting with FDA Regarding its Phase 3 Study to Evaluate the Safety and Efficacy of CX-101
Read moreSeptember 30, 2021
Currax Pharmaceuticals Hosted Ribbon-Cutting Ceremony to Mark the Opening of its Nashville Headquarters
Read moreAugust 2, 2021
Currax Pharmaceuticals Moves Global Headquarters to Brentwood, Tennessee
Read moreJune 25, 2021
Currax Launches Why Weight: Communicate Initiative to Encourage Conversations about Weight Loss
Read moreFebruary 27, 2020
Currax Pharmaceuticals Delivers Strong Operational and Financial Performance Eight Months into Operations
Read moreSeptember 27, 2019
Currax™ Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
Read moreSeptember 26, 2019
Currax™ Pharmaceuticals LLC Announces First Acquisition: Acquires North American Rights to ONZETRA® Xsail®
Read moreMay 1, 2019